<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: tb patients</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Steroids may help reduce deaths from all types of tuberculosis</title>
   	 <description>The routine use of steroids to treat tuberculosis may help reduce deaths from all types of the disease, according to a new review of existing research.</description>
     <link>http://medicalxpress.com/news/2013-03-steroids-deaths-tuberculosis.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 12 Mar 2013 07:37:26 EST</pubDate>
	 <guid isPermaLink="false">news282292585</guid>
	 
</item>
<item>
     <title>Team finds molecule that polices TB lung infection, could lead to vaccine</title>
   	 <description>The presence of a certain molecule allows the immune system to effectively police tuberculosis (TB) of the lungs and prevent it from turning into an active and deadly infection, according to a new study led by researchers at Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine. Their findings appear today in the online version of the Journal of Clinical Investigation.</description>
     <link>http://medicalxpress.com/news/2013-01-team-molecule-polices-tb-lung.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 02 Jan 2013 12:00:01 EST</pubDate>
	 <guid isPermaLink="false">news276343612</guid>
	 
</item>
<item>
     <title>India wages hi-tech war on ancient TB scourge</title>
   	 <description>(AP)—Shammo Khan walks into a dusty courtyard that reeks of garbage, searching for the fingerprint of a man exhausted by HIV, drug withdrawal and the tuberculosis lesions hijacking his lungs.</description>
     <link>http://medicalxpress.com/news/2012-11-india-wages-hi-tech-war-ancient.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Sun, 11 Nov 2012 14:52:17 EST</pubDate>
	 <guid isPermaLink="false">news271867926</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/indiawageshi.jpg" width="90" height="90" />
</item>
<item>
     <title>Low cost pain drug can kill resistant tuberculosis</title>
   	 <description>An off-patent anti-inflammatory drug that costs around two cents for a daily dose in developing countries has been found by researchers at Weill Cornell Medical College to kill both replicating and non-replicating drug resistant tuberculosis in the laboratory—a feat few currently approved TB drugs can do, and resistance to those is spreading.</description>
     <link>http://medicalxpress.com/news/2012-09-pain-drug-resistant-tuberculosis.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 10 Sep 2012 16:20:05 EST</pubDate>
	 <guid isPermaLink="false">news266512213</guid>
	 
</item>
<item>
     <title>Low cost pain drug can kill resistant tuberculosis</title>
   	 <description>An off-patent anti-inflammatory drug that costs around two cents for a daily dose in developing countries has been found by researchers at Weill Cornell Medical College to kill both replicating and non-replicating drug resistant tuberculosis in the laboratory—a feat few currently approved TB drugs can do, and resistance to those is spreading.</description>
     <link>http://medicalxpress.com/news/2012-09-pain-drug-resistant-tuberculosis.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 10 Sep 2012 16:20:05 EST</pubDate>
	 <guid isPermaLink="false">news266512213</guid>
	 
</item>
<item>
     <title>High doses of Vitamin D help tuberculosis patients recover more quickly</title>
   	 <description>For decades before antibiotics became generally available, sunshine was used to treat tuberculosis, with patients often being sent to Swiss clinics to soak up the sun's healing rays. Now, for the first time scientists have shown how and why heliotherapy might, indeed, have made a difference.</description>
     <link>http://medicalxpress.com/news/2012-09-high-doses-vitamin-d-tuberculosis.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 03 Sep 2012 15:00:23 EST</pubDate>
	 <guid isPermaLink="false">news265889620</guid>
	 
</item>
<item>
     <title>International study reveals alarming levels of extensively drug-resistant tuberculosis</title>
   	 <description>A large, international study published Online First in The Lancet reveals alarming levels of tuberculosis (TB) that are resistant to both first-line and second-line drugs. The findings show high prevalence of resistance to at least one second-line drug (43.7%) among multidrug-resistant (MDR) TB patients from eight countries in Africa, Asia, Europe, and Latin America. Worse still, the study found higher than expected overall levels of extensively drug-resistant (XDR) TB.</description>
     <link>http://medicalxpress.com/news/2012-08-international-reveals-alarming-extensively-drug-resistant.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 29 Aug 2012 18:30:01 EST</pubDate>
	 <guid isPermaLink="false">news265479566</guid>
	 
</item>
<item>
     <title>Scientists: Novel TB drug combo passes first test</title>
   	 <description>Scientists are hot on the trail of a new tuberculosis treatment that a small study suggests might one day offer an alternative to battle this deadly lung disease, even if it is resistant to today's two main drugs.</description>
     <link>http://medicalxpress.com/news/2012-07-scientists-tb-drug-combo.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 23 Jul 2012 17:13:00 EST</pubDate>
	 <guid isPermaLink="false">news262282368</guid>
	 
</item>
<item>
     <title>UCSF/SFGH researchers call for change in new FDA recommendation on HIV and TB drug doses</title>
   	 <description>In January, 2012, the U.S. Food and Drug Administration (FDA) issued new guidelines on dosing of an HIV medication used to treat people infected with both HIV and tuberculosis (TB) because of a potential interaction between two of the main drugs used to treat each disease.</description>
     <link>http://medicalxpress.com/news/2012-07-ucsfsfgh-fda-hiv-tb-drug.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 23 Jul 2012 17:09:20 EST</pubDate>
	 <guid isPermaLink="false">news262282154</guid>
	 
</item>
<item>
     <title>78 TB cases at Tokyo elderly care hospital: report</title>
   	 <description> The Tokyo Metropolitan Government said Monday 78 patients and staff at an elderly care center had contracted tuberculosis (TB), including three people who died, a report said.</description>
     <link>http://medicalxpress.com/news/2012-07-tb-cases-tokyo-elderly-hospital.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 09 Jul 2012 08:40:15 EST</pubDate>
	 <guid isPermaLink="false">news261042004</guid>
	 
</item>
<item>
     <title>Madagascar battles surge in TB cases</title>
   	 <description> After enduring six months of pain that grew so intense she could no longer work, Perline Razanadravao finally decided to go with her equally sick baby to see a doctor.</description>
     <link>http://medicalxpress.com/news/2012-07-madagascar-surge-tb-cases.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 09 Jul 2012 04:28:22 EST</pubDate>
	 <guid isPermaLink="false">news261026858</guid>
	 
</item>
<item>
     <title>S.Africa conducts trials for shorter TB treatment</title>
   	 <description> South African researchers said Friday they were conducting medical trials to shorten the duration of tuberculosis treatment to make it easier for patients to complete the full regimen.</description>
     <link>http://medicalxpress.com/news/2012-03-safrica-trials-shorter-tb-treatment.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 30 Mar 2012 09:38:14 EST</pubDate>
	 <guid isPermaLink="false">news252319081</guid>
	 
</item>
<item>
     <title>Researchers validate preclinical effectiveness of TB drug target</title>
   	 <description>In research at SRI International, scientists evaluating new drug targets against tuberculosis (TB) recently validated the preclinical effectiveness of a target that could rapidly eliminate infections and potentially shorten treatment time. The new drug target is a protein called DNA gyrase B, found in bacteria that cause TB infections.</description>
     <link>http://medicalxpress.com/news/2011-11-validate-preclinical-effectiveness-tb-drug.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 29 Nov 2011 15:50:20 EST</pubDate>
	 <guid isPermaLink="false">news241804191</guid>
	 
</item>
<item>
     <title>New WHO guidelines call for more evidence on drug-resistant TB</title>
   	 <description>The European Respiratory Journal is today (04 August 2011) publishing the updated guidelines of the World Health Organization (WHO) that aim to help manage drug-resistant tuberculosis (TB).</description>
     <link>http://medicalxpress.com/news/2011-08-guidelines-evidence-drug-resistant-tb.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 04 Aug 2011 04:10:01 EST</pubDate>
	 <guid isPermaLink="false">news231646925</guid>
	 
</item>


</channel>
</rss>
